IQARUS MEDICAL SERVICES LIMITEDActive

Company number 10451015Private limited companyIncorporated 2016
⚠ Confirmation statement overdue. It was due on 23 Oct 2026.

Key figures

−£41,563+99.3%
Net assets 2024/25
-8 m-6 m-4 m-2 m02022/232023/242024/25

Like most small UK companies, IQARUS MEDICAL SERVICES LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
00.512022/232023/242024/25
Filed accounts2022/23–2024/25
2022/232023/242024/25
Total assets———
Total liabilities———
Net assets / total equity-5,977,329-6,023,991-41,563
Average number of employees000

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Principal activity

Accounts 2025

The principal activity of the company continued to be that of a holding company for the investment in the Iqarus Medical Center (formerly American Medical Center). However this subsidiary has permanently ceased trading.

As described in the company's latest filed accounts.

Summary: IQARUS MEDICAL SERVICES LIMITED

Company

IQARUS MEDICAL SERVICES LIMITED is a private limited company registered with Companies House under company number 10451015. It was incorporated on 28 Oct 2016. Its status is active. The registered office is in London (W4). Its nature of business (SIC 2007) is general medical practice activities (86210).

Accounts

The latest accounts in the database are for 2024/25 (period ending 30 Jun 2025); the company files full accounts. Net assets were −£41,563, up 99.3% on the previous year. The company had an average of 0 employees. Figures are available for 3 financial years (2022/23–2024/25).

Control and charges

2 persons with significant control are registered.

Filing deadlines

The next accounts are due by 31 Mar 2027. The next confirmation statement is due by 23 Oct 2026.